生命科学资讯

Quanterix nabs Illumina’s CCO as new leader, but Leerink warns of ‘significant lift’ needed for turnaround - Fierce Biotech

Krystal Biotech says it can deliver native protein to cystic fibrosis patients

Former NIH genomics director Eric Green to join Illumina as CMO - statnews.com

J&J strikes drug pricing, tariff deal with the White House

Multi-omics and perturbation screens as discovery tools in immunometabolism

Sensory sharpening and semantic prediction errors unify competing models of predictive processing in human speech comprehension

Former Roche oncology head turns to Tubulis—Chutes & Ladders - fiercebiotech.com

Roche returns to Chinese biotech MediLink for another ADC pact

Roche returns to Chinese biotech MediLink for another ADC pact - Endpoints News

AirNexis gets $200M to test China-derived COPD drug

Roche divulges new NLRP3 inflammasome inhibitors

Hansoh describes new TNF-α inhibitors for autoimmune diseases

Radiotracer for positron emission tomography against PKM2

Ukko eyes clinic with UKK-0018 for peanut allergy

PharmaVoice’s Crystal Ball: What’s next for AI and drug R&D

Speculation builds about a deal for Revolution Medicines

Illumina hires former NHGRI Director Eric Green as new chief medical officer

1st biotech IPO of 2026 sees Aktis bring in $318M via upsized offering

Roche returns to MediLink with promise of $570M near-term payments for another ADC

Medipost gets $140M to take Korean stem cell therapy into US